SPIA
NVCR icon

Steward Partners Investment Advisory’s NovoCure NVCR Stock Holding History

Steward Partners Investment Advisory’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22K Buy
2,019
+1,900
+1,597% +$23.7K ﹤0.01% 3182
2025
Q4 		$1.54K Sell
119
-1
-0.8% -$13 ﹤0.01% 4016
2025
Q3 		$1.55K Buy
120
+20
+20% +$267 ﹤0.01% 3983
2025
Q2 		$1.78K Hold
100
– – ﹤0.01% 3761
2025
Q1 		$1.78K Sell
100
-349
-78% -$7.93K ﹤0.01% 3669
2024
Q4 		$13.4K Sell
449
-50
-10% -$1.06K ﹤0.01% 2973
2024
Q3 		$7.8K Sell
499
-250
-33% -$4.53K ﹤0.01% 3045
2024
Q2 		$12.8K Buy
749
+40
+6% +$703 ﹤0.01% 2718
2024
Q1 		$11.1K Hold
709
– – ﹤0.01% 2768
2023
Q4 		$10.6K Hold
709
– – ﹤0.01% 2682
2023
Q3 		$11.4K Sell
709
-100
-12% -$2.88K ﹤0.01% 2543
2023
Q2 		$33.6K Hold
809
– – ﹤0.01% 2050
2023
Q1 		$48.7K Hold
809
– – ﹤0.01% 1873
2022
Q4 		$59.3K Hold
809
– – ﹤0.01% 1766
2022
Q3 		$61K Sell
809
-30
-4% -$2.34K ﹤0.01% 1701
2022
Q2 		$58K Sell
839
-20
-2% -$1.51K ﹤0.01% 1731
2022
Q1 		$71K Hold
859
– – ﹤0.01% 1749
2021
Q4 		$64K Sell
859
-220
-20% -$22.1K ﹤0.01% 1785
2021
Q3 		$125K Sell
1,079
-40
-4% -$6.05K ﹤0.01% 1460
2021
Q2 		$248K Sell
1,119
-75
-6% -$14.6K ﹤0.01% 1402
2021
Q1 		$158K Sell
1,194
-70
-6% -$11.1K ﹤0.01% 1402
2020
Q4 		$219K Buy
1,264
+1,064
+532% +$146K ﹤0.01% 1036
2020
Q3 		$22K Hold
200
– – ﹤0.01% 1861
2020
Q2 		$12K Hold
200
– – ﹤0.01% 1968
2020
Q1 		$13K Hold
200
– – ﹤0.01% 1761
2019
Q4 		$16K Hold
200
– – ﹤0.01% 1838
2019
Q3 		$14K Buy
+200
New +$16K ﹤0.01% 1852

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Steward Partners Investment Advisory's NVCR Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its NovoCure (NVCR) stake by 1,597% in Q1 2026, buying an estimated $23.7K and bringing the position to 2,019 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #3182.

Steward Partners Investment Advisory first reported a position in NVCR in Q3 2019 and has held it in 27 quarters since. The position peaked at $248K in Q2 2021. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Steward Partners Investment Advisory held 2,019 shares of NovoCure worth $22K as of Q1 2026.
  • Steward Partners Investment Advisory bought 1,900 NovoCure shares in Q1 2026, an estimated $23.7K.
  • NovoCure made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3182 holding.
  • Steward Partners Investment Advisory first reported a position in NovoCure in Q3 2019 and has held it in 27 quarters since.
  • Steward Partners Investment Advisory's NovoCure position peaked at $248K in Q2 2021.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.